AI Act Is Officially Published: Implementation Challenges Ahead For Medtech

The final text of the AI Act is now available for all to read but, for medtech, it may feel that work is only just beginning.

airport runway under the sun as background
It's Take Off Time Now For The EU's AI Act

The text of the EU’s AI Act, which lays the foundation for responsible development of AI across all industrial sectors, was published in the Official Journal of the EU on 13 July and is due to enter into force on 2 August.

The deadline for the application of Regulation (EU) 2024/1689 to AI-enabled medical technologies already regulated under the Medical Device Regulation...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

EU Digital Omnibus Meets MDR And IVDR Revisions: Alignment Or Chaos?

 

Simultaneous revisions of the EU’s AI, data and medtech rules offer opportunities for simplification and alignment but also risk confusion and competing priorities. With political tensions in the background, does all this portend further unwanted compromises or delays for medtech?

Long-Awaited EUDAMED Notice Ushers In New Era Of Compliance

 

After years of delays - and even skepticism in Rome last month when officials hinted at its imminent debut - the long-awaited EUDAMED medical device database release has finally been confirmed

Proposed Revision Of Digital Rules – EU’s Good Start But Medtech Advises Caution

 

The European Commission’s Digital Omnibus Package promises to simplify EU complex digital compliance processes, but is it taking the EU in the right direction in its simplification efforts?

How The EU’s Digital Omnibus Package Could Provide Breathing Space For Medtech

 

The European Commission seems to have heeded many of the medtech industry’s points regarding challenges with the implementation of the AI Act within the Digital Omnibus. But the usual EU hurdles must be crossed before the sector will know if these proposals will make it into law.

More from Geography

interview

What Exact-ly Is In Store For Liquid Biopsy?

 

Ahead of Exact Science’s $21bn dollar acquisition by Abbott, Medtech Insight spoke to the company’s chief medical officer, Tomasz Beer, to learn more about the company’s multi-cancer early detection offering, its wider portfolio of products and to hear more about the direction of the field.

LDTs Aimed At Catching Cancers Early Hold Promise In Reducing Late-Stage Diagnoses, Study Shows

 

A recent study demonstrates that certain types of blood-based tests that screen for multiple cancers at once have the potential to flip the script on cancer diagnoses, including some of the deadliest types.

How The EU’s Digital Omnibus Package Could Provide Breathing Space For Medtech

 

The European Commission seems to have heeded many of the medtech industry’s points regarding challenges with the implementation of the AI Act within the Digital Omnibus. But the usual EU hurdles must be crossed before the sector will know if these proposals will make it into law.